Parallax Health Sciences to Participate at the Planet MicroCap Showcase 2019

Parallax Health Sciences, Inc.

Companies Mentioned:

Primary Exchange: OTCQX
Under the Symbol: PRLX

Parallax Health Sciences to Participate at the Planet MicroCap Showcase 2019

Thursday, April 25, 2019 2:25 PM

SANTA MONICA, CA / ACCESSWIRE / April 25, 2019 / Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, announces that management will present at the Planet MicroCap Showcase on Wednesday, May 1, 2019 at 4:30 p.m. Pacific time and conduct individual investors meetings on Thursday, May 2, 2019.

The conference will be held April 30-May 2, 2019 at Bally's Hotel & Casino in Las Vegas. For those interested in meeting with management, please contact Robert Kraft at [email protected] or (424) 227-9018, or visit www.planetmicrocapshowcase.com for more information.

About Parallax Health Sciences

Parallax Health Sciences is an advanced technology, outcome-driven telehealth company that allows for cost-effective remote diagnosis, treatment and monitoring of patients through proprietary platforms of integrated products and services. The Company's interoperable novel applications provide patients point-of-care testing and monitoring with information communicated via internet-based mobile phone applications that are agnostic as to operating system and are built on highly sophisticated data analytics. Information is retrieved real-time by physicians who are monitoring patients with chronic diseases or through biometric feedback for health-related behavior modification, and is automated for integration into electronic health records. The Company's products and offerings capitalize on the digital transformation in healthcare for improved patient compliance, diagnosis and treatment, and support healthcare system cost savings and efficiencies. For more information, please visit www.parallaxcare.com.

Forward-Looking Statements

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in our Form 10-K and other reports filed with the SEC. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contact:

LHA Investor Relations
Jody Cain [email protected]
Kevin Mc Cabe [email protected]
310-691-7100

SOURCE: Parallax Health Sciences, Inc.


SHARE ARTICLE